Table 1.
Patient characteristics
| Fosnetupitant (N = 392) |
Fosaprepitant (N = 393) |
|
|---|---|---|
| Age | ||
| Median (range) | 67.0 (40–81) | 66.0 (33–82) |
| Age [n (%)] | ||
| < 55 years | 50 (12.8) | 50 (12.7) |
| ≥ 55 years | 342 (87.2) | 343 (87.3) |
| Sex [n (%)] | ||
| Male | 301 (76.8) | 302 (76.8) |
| Female | 91 (23.2) | 91 (23.2) |
| Cancer type [n (%)] | ||
| Lung | 353 (90.1) | 341 (86.8) |
| Esophagus | 21 (5.4) | 24 (6.1) |
| Head and neck | 7 (1.8) | 10 (2.5) |
| Other | 11 (2.8) | 18 (4.6) |
| Dose of cisplatin (mg/m2) [n (%)] | ||
| ≥ 70 to < 80 | 144 (36.7) | 165 (42.0) |
| ≥ 80 to < 90 | 243 (62.0) | 221 (56.2) |
| ≥ 90 | 5 (1.3) | 7 (1.8) |